The Board of Directors of PharmaBlock Sciences (Nanjing), Inc. has authorized a buyback plan on October 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.26 CNY | -4.32% |
|
-7.69% | -30.58% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.58% | 736M | |
+55.31% | 815B | |
+45.31% | 654B | |
-6.71% | 354B | |
+21.58% | 337B | |
+9.91% | 302B | |
+17.85% | 247B | |
+2.09% | 229B | |
+12.97% | 219B | |
+9.80% | 171B |
- Stock Market
- Equities
- 300725 Stock
- News PharmaBlock Sciences (Nanjing), Inc.
- PharmaBlock Sciences, Inc. authorizes a Buyback Plan.